Melanie Everitt
Concepts (296)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Transplantation | 53 | 2023 | 671 | 9.260 |
Why?
| Graft Rejection | 21 | 2022 | 532 | 3.330 |
Why?
| Heart Defects, Congenital | 14 | 2023 | 666 | 2.710 |
Why?
| Cardiomyopathies | 10 | 2024 | 301 | 2.210 |
Why?
| Waiting Lists | 10 | 2023 | 222 | 1.520 |
Why?
| Cardiomyopathy, Dilated | 8 | 2024 | 351 | 1.490 |
Why?
| Registries | 16 | 2024 | 1765 | 1.420 |
Why?
| Fontan Procedure | 5 | 2023 | 160 | 1.100 |
Why?
| Antibodies | 8 | 2022 | 372 | 1.060 |
Why?
| Extracorporeal Membrane Oxygenation | 2 | 2021 | 242 | 1.060 |
Why?
| Heart Diseases | 6 | 2019 | 331 | 1.050 |
Why?
| Postoperative Complications | 10 | 2021 | 2158 | 0.960 |
Why?
| Donor Selection | 3 | 2020 | 73 | 0.890 |
Why?
| Child | 49 | 2024 | 18468 | 0.880 |
Why?
| Survival Rate | 18 | 2021 | 1650 | 0.860 |
Why?
| Heart Failure | 12 | 2023 | 1962 | 0.860 |
Why?
| Tissue Donors | 5 | 2020 | 330 | 0.850 |
Why?
| Ventricular Dysfunction | 2 | 2013 | 16 | 0.850 |
Why?
| Heart-Assist Devices | 8 | 2023 | 485 | 0.790 |
Why?
| Heterotaxy Syndrome | 1 | 2021 | 10 | 0.770 |
Why?
| Marfan Syndrome | 2 | 2011 | 43 | 0.710 |
Why?
| Child, Preschool | 29 | 2023 | 9124 | 0.690 |
Why?
| Retrospective Studies | 28 | 2023 | 12597 | 0.670 |
Why?
| Societies, Medical | 2 | 2021 | 680 | 0.660 |
Why?
| General Practice | 1 | 2019 | 27 | 0.660 |
Why?
| Coronary Vessels | 2 | 2018 | 230 | 0.640 |
Why?
| Primary Graft Dysfunction | 1 | 2019 | 32 | 0.640 |
Why?
| Aortic Aneurysm, Thoracic | 2 | 2011 | 122 | 0.640 |
Why?
| Myocardium | 9 | 2023 | 925 | 0.620 |
Why?
| Neurodevelopmental Disorders | 1 | 2019 | 109 | 0.600 |
Why?
| Medication Adherence | 2 | 2019 | 537 | 0.580 |
Why?
| Infant | 25 | 2023 | 7966 | 0.560 |
Why?
| Humans | 80 | 2024 | 115222 | 0.550 |
Why?
| Adolescent | 32 | 2023 | 17889 | 0.550 |
Why?
| Follow-Up Studies | 15 | 2021 | 4430 | 0.530 |
Why?
| Male | 52 | 2023 | 55814 | 0.500 |
Why?
| Ventricular Dysfunction, Left | 3 | 2014 | 366 | 0.490 |
Why?
| Ventricular Remodeling | 3 | 2024 | 227 | 0.480 |
Why?
| Tissue and Organ Procurement | 5 | 2022 | 243 | 0.470 |
Why?
| Cardiomyopathy, Hypertrophic | 4 | 2023 | 122 | 0.450 |
Why?
| Echocardiography, Doppler | 1 | 2014 | 93 | 0.440 |
Why?
| Female | 50 | 2023 | 59720 | 0.440 |
Why?
| Hemodynamics | 4 | 2022 | 1024 | 0.430 |
Why?
| Biopsy | 8 | 2022 | 1050 | 0.430 |
Why?
| Coronary Artery Disease | 1 | 2018 | 607 | 0.420 |
Why?
| Risk Factors | 13 | 2023 | 8658 | 0.420 |
Why?
| Arrhythmias, Cardiac | 3 | 2013 | 279 | 0.420 |
Why?
| Patient Selection | 2 | 2014 | 651 | 0.420 |
Why?
| Vascular Remodeling | 1 | 2014 | 154 | 0.410 |
Why?
| Death, Sudden, Cardiac | 2 | 2012 | 160 | 0.410 |
Why?
| Graft Survival | 5 | 2022 | 479 | 0.390 |
Why?
| Aneurysm | 1 | 2011 | 29 | 0.390 |
Why?
| American Heart Association | 3 | 2019 | 264 | 0.390 |
Why?
| Immunosuppressive Agents | 4 | 2022 | 667 | 0.380 |
Why?
| Electrocardiography | 2 | 2014 | 563 | 0.380 |
Why?
| Protein-Losing Enteropathies | 1 | 2011 | 11 | 0.380 |
Why?
| Treatment Outcome | 14 | 2023 | 9151 | 0.370 |
Why?
| Anemia, Iron-Deficiency | 1 | 2011 | 54 | 0.360 |
Why?
| Defibrillators | 1 | 2010 | 16 | 0.350 |
Why?
| Blood Group Incompatibility | 1 | 2009 | 13 | 0.340 |
Why?
| Ventricular Fibrillation | 1 | 2010 | 51 | 0.340 |
Why?
| ABO Blood-Group System | 1 | 2009 | 32 | 0.340 |
Why?
| Aortic Valve | 2 | 2014 | 397 | 0.330 |
Why?
| Kidney Diseases | 2 | 2023 | 351 | 0.330 |
Why?
| Craniofacial Abnormalities | 1 | 2009 | 59 | 0.320 |
Why?
| Mitral Valve | 1 | 2009 | 86 | 0.310 |
Why?
| Kidney Transplantation | 3 | 2023 | 553 | 0.310 |
Why?
| Infant, Newborn | 11 | 2021 | 5052 | 0.310 |
Why?
| Tachycardia, Ventricular | 1 | 2010 | 153 | 0.300 |
Why?
| Severity of Illness Index | 6 | 2018 | 2552 | 0.300 |
Why?
| Heart Ventricles | 4 | 2017 | 720 | 0.300 |
Why?
| Incidence | 6 | 2019 | 2324 | 0.290 |
Why?
| Aorta, Thoracic | 1 | 2009 | 261 | 0.270 |
Why?
| Perioperative Care | 2 | 2017 | 125 | 0.270 |
Why?
| Prognosis | 8 | 2018 | 3336 | 0.260 |
Why?
| Palliative Care | 1 | 2012 | 640 | 0.260 |
Why?
| Peripheral Arterial Disease | 1 | 2011 | 380 | 0.260 |
Why?
| Risk Assessment | 4 | 2023 | 2981 | 0.240 |
Why?
| Transplants | 2 | 2022 | 37 | 0.240 |
Why?
| Databases, Factual | 1 | 2009 | 1136 | 0.240 |
Why?
| Vascular Resistance | 3 | 2014 | 338 | 0.240 |
Why?
| Adult | 22 | 2023 | 30711 | 0.230 |
Why?
| Genetic Testing | 3 | 2022 | 380 | 0.230 |
Why?
| Young Adult | 13 | 2023 | 10520 | 0.230 |
Why?
| Heart | 3 | 2023 | 613 | 0.220 |
Why?
| Time Factors | 6 | 2017 | 6157 | 0.220 |
Why?
| Transplantation, Homologous | 3 | 2021 | 394 | 0.210 |
Why?
| Contrast Media | 2 | 2023 | 369 | 0.210 |
Why?
| Inheritance Patterns | 1 | 2022 | 45 | 0.200 |
Why?
| Hypoplastic Left Heart Syndrome | 2 | 2014 | 114 | 0.200 |
Why?
| Prospective Studies | 7 | 2023 | 6245 | 0.190 |
Why?
| Magnetic Resonance Imaging, Cine | 3 | 2023 | 183 | 0.190 |
Why?
| Echocardiography | 6 | 2018 | 563 | 0.190 |
Why?
| Phenotype | 4 | 2022 | 2814 | 0.180 |
Why?
| Exome | 1 | 2022 | 201 | 0.180 |
Why?
| Organ Transplantation | 1 | 2023 | 161 | 0.180 |
Why?
| Clinical Decision-Making | 1 | 2022 | 268 | 0.170 |
Why?
| Genetic Predisposition to Disease | 4 | 2022 | 2109 | 0.170 |
Why?
| Respiratory Insufficiency | 1 | 2023 | 292 | 0.170 |
Why?
| Noonan Syndrome | 1 | 2019 | 17 | 0.160 |
Why?
| Attention Deficit Disorder with Hyperactivity | 1 | 2023 | 363 | 0.160 |
Why?
| Global Health | 1 | 2021 | 288 | 0.160 |
Why?
| Neuropsychological Tests | 2 | 2021 | 913 | 0.160 |
Why?
| Proportional Hazards Models | 7 | 2017 | 1082 | 0.160 |
Why?
| Cohort Studies | 6 | 2022 | 4917 | 0.160 |
Why?
| Kidney Failure, Chronic | 1 | 2023 | 489 | 0.160 |
Why?
| United States | 13 | 2021 | 12256 | 0.150 |
Why?
| Hyperplasia | 1 | 2018 | 165 | 0.150 |
Why?
| Child Nutrition Disorders | 1 | 2018 | 16 | 0.150 |
Why?
| Kaplan-Meier Estimate | 2 | 2017 | 816 | 0.150 |
Why?
| Survival Analysis | 4 | 2021 | 1215 | 0.150 |
Why?
| Surgical Wound Dehiscence | 1 | 2017 | 20 | 0.150 |
Why?
| Consensus | 1 | 2020 | 534 | 0.150 |
Why?
| Cognition Disorders | 1 | 2021 | 475 | 0.140 |
Why?
| Executive Function | 1 | 2021 | 375 | 0.140 |
Why?
| Death | 1 | 2017 | 109 | 0.140 |
Why?
| Genotype | 1 | 2022 | 1781 | 0.140 |
Why?
| Predictive Value of Tests | 3 | 2017 | 1816 | 0.140 |
Why?
| Sirolimus | 1 | 2017 | 189 | 0.140 |
Why?
| Ventricular Function, Left | 2 | 2024 | 474 | 0.140 |
Why?
| Extracorporeal Circulation | 1 | 2016 | 14 | 0.130 |
Why?
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2015 | 3 | 0.130 |
Why?
| Cardio-Renal Syndrome | 1 | 2015 | 10 | 0.130 |
Why?
| Genes, Neurofibromatosis 1 | 1 | 2015 | 4 | 0.120 |
Why?
| Pseudarthrosis | 1 | 2015 | 7 | 0.120 |
Why?
| Cardiology | 1 | 2017 | 259 | 0.120 |
Why?
| Surgical Wound Infection | 1 | 2017 | 248 | 0.120 |
Why?
| Referral and Consultation | 1 | 2019 | 637 | 0.120 |
Why?
| Fluorescent Antibody Technique | 1 | 2015 | 396 | 0.120 |
Why?
| Cardiovascular Diseases | 3 | 2012 | 1731 | 0.120 |
Why?
| Neurofibromatosis 1 | 1 | 2015 | 36 | 0.120 |
Why?
| Tachycardia | 1 | 2014 | 50 | 0.120 |
Why?
| Pulmonary Wedge Pressure | 1 | 2014 | 64 | 0.110 |
Why?
| Middle Aged | 13 | 2017 | 26873 | 0.110 |
Why?
| Pediatrics | 3 | 2016 | 986 | 0.110 |
Why?
| Hospitals, Pediatric | 1 | 2017 | 477 | 0.110 |
Why?
| Sequence Deletion | 1 | 2014 | 168 | 0.110 |
Why?
| T-Box Domain Proteins | 1 | 2014 | 92 | 0.110 |
Why?
| Arterial Pressure | 1 | 2014 | 100 | 0.110 |
Why?
| Tibia | 1 | 2015 | 169 | 0.110 |
Why?
| Reoperation | 2 | 2021 | 524 | 0.110 |
Why?
| Age Distribution | 1 | 2014 | 341 | 0.110 |
Why?
| Sex Distribution | 1 | 2014 | 337 | 0.110 |
Why?
| Age Factors | 2 | 2017 | 2900 | 0.110 |
Why?
| Gene Expression Regulation | 1 | 2022 | 2330 | 0.100 |
Why?
| Cardiomyopathy, Restrictive | 1 | 2012 | 9 | 0.100 |
Why?
| Anxiety | 1 | 2019 | 846 | 0.100 |
Why?
| Abnormalities, Multiple | 1 | 2014 | 177 | 0.100 |
Why?
| Liver Diseases | 1 | 2014 | 263 | 0.100 |
Why?
| Healthcare Disparities | 1 | 2017 | 480 | 0.100 |
Why?
| Fibrosis | 3 | 2023 | 455 | 0.100 |
Why?
| Immunoglobulins | 1 | 2012 | 143 | 0.100 |
Why?
| Capillaries | 1 | 2012 | 92 | 0.100 |
Why?
| International Cooperation | 1 | 2012 | 172 | 0.100 |
Why?
| Glucaric Acid | 1 | 2011 | 3 | 0.100 |
Why?
| Pediatric Obesity | 1 | 2018 | 493 | 0.090 |
Why?
| Tissue and Organ Harvesting | 1 | 2011 | 69 | 0.090 |
Why?
| Hematinics | 1 | 2011 | 18 | 0.090 |
Why?
| Altitude Sickness | 1 | 2013 | 172 | 0.090 |
Why?
| Stroke Volume | 1 | 2014 | 512 | 0.090 |
Why?
| Hypertrophy, Left Ventricular | 1 | 2011 | 103 | 0.090 |
Why?
| Cardiotonic Agents | 1 | 2011 | 119 | 0.090 |
Why?
| Ferric Compounds | 1 | 2011 | 40 | 0.090 |
Why?
| Treatment Failure | 1 | 2012 | 332 | 0.090 |
Why?
| Delivery of Health Care | 1 | 2017 | 836 | 0.090 |
Why?
| Adrenergic alpha-Antagonists | 1 | 2010 | 30 | 0.090 |
Why?
| Diverticulum | 1 | 2010 | 11 | 0.090 |
Why?
| Echocardiography, Doppler, Color | 1 | 2010 | 38 | 0.090 |
Why?
| Disease Management | 1 | 2014 | 562 | 0.090 |
Why?
| Recovery of Function | 1 | 2014 | 577 | 0.090 |
Why?
| Mutation | 3 | 2019 | 3350 | 0.090 |
Why?
| Carbazoles | 1 | 2010 | 80 | 0.090 |
Why?
| Propanolamines | 1 | 2010 | 94 | 0.090 |
Why?
| Negative-Pressure Wound Therapy | 1 | 2009 | 13 | 0.090 |
Why?
| Blood Component Transfusion | 1 | 2010 | 76 | 0.090 |
Why?
| Magnetic Resonance Angiography | 1 | 2011 | 240 | 0.080 |
Why?
| Resource Allocation | 1 | 2009 | 37 | 0.080 |
Why?
| Cross-Sectional Studies | 1 | 2019 | 4419 | 0.080 |
Why?
| Dopamine | 1 | 2011 | 236 | 0.080 |
Why?
| Practice Patterns, Physicians' | 1 | 2017 | 1178 | 0.080 |
Why?
| Myocardial Contraction | 1 | 2010 | 314 | 0.080 |
Why?
| Immune Tolerance | 1 | 2010 | 329 | 0.080 |
Why?
| Pulmonary Artery | 1 | 2014 | 1032 | 0.080 |
Why?
| Syndrome | 1 | 2009 | 338 | 0.080 |
Why?
| Multivariate Analysis | 3 | 2017 | 1436 | 0.070 |
Why?
| Connexin 43 | 1 | 2007 | 23 | 0.070 |
Why?
| Wound Healing | 1 | 2009 | 259 | 0.070 |
Why?
| Defibrillators, Implantable | 1 | 2010 | 286 | 0.070 |
Why?
| Risk | 1 | 2010 | 816 | 0.070 |
Why?
| Heart Valve Prosthesis Implantation | 1 | 2009 | 175 | 0.070 |
Why?
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2007 | 35 | 0.070 |
Why?
| Health Care Surveys | 2 | 2020 | 538 | 0.070 |
Why?
| Morbidity | 2 | 2021 | 279 | 0.070 |
Why?
| Biomarkers | 4 | 2023 | 3422 | 0.070 |
Why?
| Health Policy | 1 | 2009 | 333 | 0.070 |
Why?
| Tomography, X-Ray Computed | 2 | 2014 | 2344 | 0.070 |
Why?
| Cadherins | 1 | 2007 | 175 | 0.070 |
Why?
| Patient Compliance | 1 | 2010 | 525 | 0.070 |
Why?
| Canada | 2 | 2017 | 323 | 0.060 |
Why?
| Myocytes, Cardiac | 1 | 2007 | 451 | 0.050 |
Why?
| Allografts | 1 | 2023 | 124 | 0.050 |
Why?
| Gadolinium | 1 | 2023 | 78 | 0.050 |
Why?
| Aged | 4 | 2017 | 19136 | 0.050 |
Why?
| Calcineurin Inhibitors | 1 | 2022 | 60 | 0.050 |
Why?
| Cause of Death | 2 | 2015 | 367 | 0.050 |
Why?
| Quality of Life | 2 | 2023 | 2364 | 0.050 |
Why?
| Utah | 2 | 2012 | 60 | 0.050 |
Why?
| Glomerular Filtration Rate | 1 | 2023 | 605 | 0.040 |
Why?
| Living Donors | 1 | 2023 | 324 | 0.040 |
Why?
| Age of Onset | 1 | 2022 | 449 | 0.040 |
Why?
| Machine Learning | 1 | 2023 | 318 | 0.040 |
Why?
| Recombinant Fusion Proteins | 1 | 2022 | 616 | 0.040 |
Why?
| Proto-Oncogene Proteins c-raf | 1 | 2019 | 43 | 0.040 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 20 | 0.040 |
Why?
| Genes, ras | 1 | 2019 | 91 | 0.040 |
Why?
| Immunity, Cellular | 2 | 2012 | 249 | 0.040 |
Why?
| Prevalence | 2 | 2015 | 2257 | 0.040 |
Why?
| ras Proteins | 1 | 2019 | 138 | 0.040 |
Why?
| Postoperative Period | 1 | 2019 | 293 | 0.040 |
Why?
| Brazil | 1 | 2017 | 92 | 0.040 |
Why?
| Adenoidectomy | 1 | 2017 | 60 | 0.040 |
Why?
| Kidney | 1 | 2023 | 1188 | 0.030 |
Why?
| Genetic Variation | 1 | 2022 | 876 | 0.030 |
Why?
| Sample Size | 1 | 2017 | 112 | 0.030 |
Why?
| United Kingdom | 1 | 2017 | 227 | 0.030 |
Why?
| Adaptation, Psychological | 1 | 2021 | 547 | 0.030 |
Why?
| Education, Medical, Continuing | 1 | 2017 | 119 | 0.030 |
Why?
| Tonsillectomy | 1 | 2017 | 72 | 0.030 |
Why?
| Antibodies, Monoclonal | 1 | 2022 | 1268 | 0.030 |
Why?
| Gadolinium DTPA | 1 | 2016 | 54 | 0.030 |
Why?
| Health Services Needs and Demand | 1 | 2017 | 246 | 0.030 |
Why?
| Drug Administration Schedule | 1 | 2017 | 721 | 0.030 |
Why?
| Gene Expression Profiling | 1 | 2022 | 1524 | 0.030 |
Why?
| Orthopedic Procedures | 1 | 2017 | 212 | 0.030 |
Why?
| Kidney Function Tests | 1 | 2015 | 141 | 0.030 |
Why?
| Analysis of Variance | 1 | 2018 | 1231 | 0.030 |
Why?
| Case-Control Studies | 1 | 2022 | 3023 | 0.030 |
Why?
| Comorbidity | 1 | 2019 | 1458 | 0.030 |
Why?
| ROC Curve | 1 | 2016 | 447 | 0.030 |
Why?
| Lower Extremity Deformities, Congenital | 1 | 2014 | 1 | 0.030 |
Why?
| Upper Extremity Deformities, Congenital | 1 | 2014 | 2 | 0.030 |
Why?
| Pandemics | 1 | 2022 | 1323 | 0.030 |
Why?
| Cardiovascular Surgical Procedures | 1 | 2014 | 30 | 0.030 |
Why?
| Breast Diseases | 1 | 2014 | 20 | 0.030 |
Why?
| Comparative Genomic Hybridization | 1 | 2014 | 28 | 0.030 |
Why?
| Practice Guidelines as Topic | 1 | 2022 | 1397 | 0.030 |
Why?
| Dilatation, Pathologic | 1 | 2014 | 58 | 0.030 |
Why?
| Ulna | 1 | 2014 | 26 | 0.030 |
Why?
| Acute Disease | 1 | 2017 | 918 | 0.030 |
Why?
| Aortic Valve Insufficiency | 1 | 2014 | 46 | 0.030 |
Why?
| Preoperative Period | 1 | 2014 | 103 | 0.030 |
Why?
| Drug Therapy | 1 | 2014 | 77 | 0.030 |
Why?
| DNA Mutational Analysis | 1 | 2015 | 372 | 0.030 |
Why?
| Heart Septal Defects, Atrial | 1 | 2014 | 51 | 0.030 |
Why?
| Cardiac Surgical Procedures | 1 | 2017 | 415 | 0.030 |
Why?
| Population Dynamics | 1 | 2013 | 128 | 0.030 |
Why?
| Radiography | 1 | 2015 | 827 | 0.030 |
Why?
| Genetic Association Studies | 1 | 2014 | 344 | 0.030 |
Why?
| Statistics as Topic | 1 | 2013 | 298 | 0.020 |
Why?
| Antigens, CD34 | 1 | 2012 | 89 | 0.020 |
Why?
| Patient Acceptance of Health Care | 1 | 2017 | 679 | 0.020 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2017 | 1214 | 0.020 |
Why?
| Coronary Angiography | 1 | 2014 | 307 | 0.020 |
Why?
| Brain Death | 1 | 2011 | 32 | 0.020 |
Why?
| Coronary Circulation | 1 | 2012 | 135 | 0.020 |
Why?
| Complement C4b | 1 | 2010 | 9 | 0.020 |
Why?
| Heart-Lung Transplantation | 1 | 2010 | 10 | 0.020 |
Why?
| Necrosis | 1 | 2011 | 211 | 0.020 |
Why?
| Ultrasonography | 1 | 2014 | 641 | 0.020 |
Why?
| Complement C3d | 1 | 2010 | 60 | 0.020 |
Why?
| Attitude of Health Personnel | 1 | 2017 | 977 | 0.020 |
Why?
| Fibrin | 1 | 2010 | 65 | 0.020 |
Why?
| Diastole | 1 | 2010 | 133 | 0.020 |
Why?
| Systole | 1 | 2010 | 173 | 0.020 |
Why?
| Chronic Disease | 1 | 2016 | 1594 | 0.020 |
Why?
| Fibrinolytic Agents | 1 | 2012 | 233 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2017 | 2806 | 0.020 |
Why?
| HLA-DR Antigens | 1 | 2010 | 221 | 0.020 |
Why?
| Oxygen | 1 | 2013 | 855 | 0.020 |
Why?
| Ischemia | 1 | 2011 | 363 | 0.020 |
Why?
| Isoantibodies | 1 | 2008 | 57 | 0.020 |
Why?
| Image Processing, Computer-Assisted | 1 | 2012 | 699 | 0.020 |
Why?
| Gap Junctions | 1 | 2007 | 58 | 0.020 |
Why?
| Cytoskeletal Proteins | 1 | 2007 | 145 | 0.020 |
Why?
| Peptide Fragments | 1 | 2010 | 668 | 0.020 |
Why?
| Dogs | 1 | 2007 | 340 | 0.020 |
Why?
| Regression Analysis | 1 | 2008 | 949 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2010 | 1860 | 0.020 |
Why?
| Disease Progression | 1 | 2013 | 2390 | 0.020 |
Why?
| Surveys and Questionnaires | 1 | 2017 | 4645 | 0.020 |
Why?
| Blotting, Western | 1 | 2007 | 1150 | 0.010 |
Why?
| Sequence Analysis, DNA | 1 | 2007 | 728 | 0.010 |
Why?
| Stroke | 1 | 2012 | 1015 | 0.010 |
Why?
| Magnetic Resonance Imaging | 1 | 2014 | 3128 | 0.010 |
Why?
| Disease Models, Animal | 1 | 2007 | 3547 | 0.010 |
Why?
| Animals | 1 | 2007 | 31884 | 0.000 |
Why?
|
|
Everitt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|